Cannassure Therapeutics Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Ada Kama
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 2.2yrs |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 2.3yrs |
Recent management updates
Recent updates
CEO
Ada Kama (53 yo)
2.2yrs
Tenure
Ms. Ada Bar Kama serves as Chief Executive Officer and Owner at Cannassure Therapeutics Ltd. since March 31, 2022 and also serves as Director since December 23, 2021.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | no data | no data | 9.17% ₪ 2.8m | |
CEO, Director & Owner | 2.4yrs | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent External Director | 5.8yrs | no data | no data | |
Independent External Director | 2.3yrs | no data | no data | |
Independent Director | 2.2yrs | no data | no data |
2.3yrs
Average Tenure
54.5yo
Average Age
Experienced Board: CSURE-M's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.